List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumococcal Polysaccharide Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Single Dose Vial
1.4.3 Pre-Filled Syringe
1.5 Market by Application
1.5.1 Global Pneumococcal Polysaccharide Vaccine Market Share by Application: 2022-2027
1.5.2 Children (2-10 Age)
1.5.3 Adult (10-64 Age)
1.5.4 Geriatric (More Than 65 Age)
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pneumococcal Polysaccharide Vaccine Market
1.8.1 Global Pneumococcal Polysaccharide Vaccine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pneumococcal Polysaccharide Vaccine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pneumococcal Polysaccharide Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pneumococcal Polysaccharide Vaccine Sales Volume Market Share by Region (2016-2021)
3.2 Global Pneumococcal Polysaccharide Vaccine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Pneumococcal Polysaccharide Vaccine Sales Volume
3.3.1 North America Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Pneumococcal Polysaccharide Vaccine Sales Volume
3.4.1 East Asia Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.5.1 Europe Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.6.1 South Asia Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.7.1 Southeast Asia Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.8.1 Middle East Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.9.1 Africa Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.10.1 Oceania Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.11.1 South America Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Pneumococcal Polysaccharide Vaccine Sales Volume (2016-2021)
3.12.1 Rest of the World Pneumococcal Polysaccharide Vaccine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Pneumococcal Polysaccharide Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Pneumococcal Polysaccharide Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pneumococcal Polysaccharide Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pneumococcal Polysaccharide Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pneumococcal Polysaccharide Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pneumococcal Polysaccharide Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pneumococcal Polysaccharide Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pneumococcal Polysaccharide Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pneumococcal Polysaccharide Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pneumococcal Polysaccharide Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pneumococcal Polysaccharide Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pneumococcal Polysaccharide Vaccine Sales Volume Market Share by Type (2016-2021)
14.2 Global Pneumococcal Polysaccharide Vaccine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Pneumococcal Polysaccharide Vaccine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Pneumococcal Polysaccharide Vaccine Consumption Volume by Application (2016-2021)
15.2 Global Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Pneumococcal Polysaccharide Vaccine Business
16.1 Merck & Co., Inc.
16.1.1 Merck & Co., Inc. Company Profile
16.1.2 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Product Specification
16.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Pfizer Inc.
16.2.1 Pfizer Inc. Company Profile
16.2.2 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Product Specification
16.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Glaxosmithkline Plc.
16.3.1 Glaxosmithkline Plc. Company Profile
16.3.2 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Product Specification
16.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Sanofi Pasteur
16.4.1 Sanofi Pasteur Company Profile
16.4.2 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Specification
16.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 China National Biotec Group
16.5.1 China National Biotec Group Company Profile
16.5.2 China National Biotec Group Pneumococcal Polysaccharide Vaccine Product Specification
16.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Astellas Pharma Inc
16.6.1 Astellas Pharma Inc Company Profile
16.6.2 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Product Specification
16.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Serum Institute of India Pvt. Ltd
16.7.1 Serum Institute of India Pvt. Ltd Company Profile
16.7.2 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Product Specification
16.7.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
17.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
17.4 Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pneumococcal Polysaccharide Vaccine Distributors List
18.3 Pneumococcal Polysaccharide Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pneumococcal Polysaccharide Vaccine (2022-2027)
20.2 Global Forecasted Revenue of Pneumococcal Polysaccharide Vaccine (2022-2027)
20.3 Global Forecasted Price of Pneumococcal Polysaccharide Vaccine (2016-2027)
20.4 Global Forecasted Production of Pneumococcal Polysaccharide Vaccine by Region (2022-2027)
20.4.1 North America Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.9 South America Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.3 Europe Market Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.6 Middle East Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.7 Africa Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.8 Oceania Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.9 South America Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Pneumococcal Polysaccharide Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
